Optical coherence tomography for MS prognosis
Purins A, Mundy L, Merlin, T, Hiller JE
Record ID 32008100165
English
Authors' results and conclusions:
Optical coherence tomography (OCT) determined retinal nerve fibre layer (RNFL) thinning may be a valid surrogate marker of multiple sclerosis (MS) disease status in a patient. In small studies OCT RNFL thinning has shown correlation with several markers of MS progression and may be used to inform patients and clinicians about the likely future course of the disease. While no formal cost effectiveness evidence was found, most authors comment that OCT is cheaper, faster and more convenient than the current standard of care, magnetic resonance imaging (MRI).
Authors' recommendations:
There is a lack of large scale trials which utilise OCT RNFL measurements in MS patients. Therefore HealthPACT has recommended that further assessment of this technology is no longer warranted.
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Humans
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Relapsing-Remitting
- Tomography, Optical Coherence
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.